Therapeutic agent-loaded fibrous scaffolds for biomedical applications

D Park, SJ Lee, DK Choi, JW Park - Pharmaceutics, 2023 - mdpi.com
Tissue engineering is a sophisticated field that involves the integration of various disciplines,
such as clinical medicine, material science, and life science, to repair or regenerate …

Biomaterials for topical and transdermal drug delivery in reconstructive transplantation

A Dhayani, S Kalita, M Mahato, P Srinath… - Nanomedicine, 2019 - Taylor & Francis
Lifelong systemic immunosuppression remains the biggest challenge in vascularized
composite allotransplantation (VCA) due to the adverse effects it causes. Since VCA is a life …

Eluted 25-hydroxyvitamin D3 from radially aligned nanofiber scaffolds enhances cathelicidin production while reducing inflammatory response in human immune …

S Chen, L Ge, H Wang, Y Cheng, S Gorantla… - Acta biomaterialia, 2019 - Elsevier
Vitamin D 3 modulates immune response, induces endogenous antimicrobial peptide
production, and enhances innate immunity to defend against infections. These findings …

Adipose-Derived Stromal Cells Delivered in Chitosan/PEG-PTMC Hydrogels Induce Adverse Outcomes in Nude Mice with Femoral Artery Ligation

FE Serack, JA Ronald, BG Amsden, DA Hess… - GEN …, 2024 - liebertpub.com
The delivery of human adipose-derived stromal cells (hASCs) to ischemic tissues represents
a promising strategy to promote vascular regeneration for patients with critical limb ischemia …

Immune evaluation of granulocyte-macrophage colony stimulating factor loaded hierarchically 3D nanofiber scaffolds in a humanized mice model

R Chen, Y Li, Y Zhuang, Y Zhang, H Wu… - … in Bioengineering and …, 2023 - frontiersin.org
Background: Immune evaluation of biomaterials for tissue regeneration is a critical
preclinical evaluation. The current evaluation criterion (ISO 10993-1 or GB/T 16886) uses …

Development of a Cell-based Regenerative Strategy to Modulate Angiogenesis and Inflammation in Ischemic Muscle

FE Serack - 2023 - search.proquest.com
The delivery of human adipose-derived stromal cells (hASCs) to ischemic tissuesrepresents
a promising strategy to promote vascular regeneration for patients with criticallimb ischemia …